Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Pharmacotherapy|March 24, 2006
Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care settingMichael F Bullano, Debra A Wertz, Grace W Yang, et al.
Pharmacoepidemiology and Drug Safety|September 14, 2025
Comparative Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1-RAs) in Type 2 Diabetes and Chronic Weight Management: A Real-World Data StudySarah Ruth Hurwitz, Stephan Lanes, Tracey Quimbo, et al.
Clinical Therapeutics|July 28, 2018
Real-world Clinical Characteristics, Treatment Patterns, and Exacerbations in US Patients With Asthma Newly Treated With OmalizumabXuehua Ke, Abhishek Kavati, Debra Wertz, et al.
Pharmacoepidemiology and Drug Safety|June 16, 2009
The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic studyMarianne Ulcickas Yood, Gerald DeLorenze, Charles P Quesenberry, et al.
Journal of Health Economics and Outcomes Research|May 23, 2024
Impact of Pre-existing Type 2 Diabetes Mellitus and Cardiovascular Disease on Healthcare Resource Utilization and Costs in Patients With COVID-19Chi Nguyen, Christopher L Crowe, Effie Kuti, et al.
Journal of Clinical Lipidology|February 19, 2013
Risk of hospitalized rhabdomyolysis associated with lipid-lowering drugs in a real-world clinical settingMark J Cziraky, Vincent J Willey, James M McKenney, et al.
Pharmacoepidemiology and Drug Safety|February 5, 2025
The Healthcare Integrated Research Database (HIRD) as a Real-World Data Source for Pharmacoepidemiologic ResearchJohn J Barron, Vincent J Willey, Brett T Doherty, et al.
The American Journal of Cardiology|April 4, 2006
Statin safety: an assessment using an administrative claims databaseMark J Cziraky, Vincent J Willey, James M McKenney, et al.
Pragmatic and Observational Research|September 13, 2017
A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims dataDavid M Kern, John J Barron, Bingcao Wu, et al.
Pragmatic and Observational Research|March 4, 2025
Treatment Patterns, Adverse Events, and Clinical Outcomes with Steroidal Mineralocorticoid Receptor Antagonists: A Retrospective Analysis of Administrative Claims Data (RELICS)Emma L Richard, Nihar R Desai, Vincent J Willey, et al.
Pageof 7